Search results 1-1 of 1 in Amyloid
Results
-
Rochester, Minn.
View Summary
International Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of KIACTA in Preventing Renal Function Decline in Patients With AA Amyloidosis
Location:
Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
The primary purpose of this study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA Amyloidosis.
NCT ID:
NCT01215747
Who can I contact for additional information about this study?
Rochester: Tammy Evans 507-284-1004